SWOG clinical trial number
SWOG-8626
Phase II Study of Recominbant DNA Gamma Interferon in Advanced Cancer of the Pancreas
Closed
Phase
Published
Abbreviated Title
Phase II Study of Recominbant DNA Gamma Interferon in Advanced Cancer of the Pancreas
Activated
05/15/1987
Closed
11/15/1988
Publication Information Expand/Collapse
1990
Phase II evaluation of recombinant gamma interferon (r-GIFN) in patients with advanced pancreatic carcinoma: A Southwest Oncology Group study.